Cognetivity To Study Use Of Cognitive Tool To Detect Concussions From Sports

Cognetivity Neuroscience (CSE: CGN) is looking to expand the scope of its cognitive testing platform. The company this morning announced that it will be undertaking a new study with Durham University, as well as My Sports Wellbeing.

Collectively, the three groups are to work together to determine the ability of the firms cognitive testing platform to detect changes in cognitive health as a result of concussions, specifically as they relate to high impact sports. The tool will be tested for the ability of detecting concussions, as well as any changes to cognitive function as a result of repeated sub concussions.

The study is to primarily focus on concussions developed as a resulting of playing rugby, as well as other community sports. It’s currently estimated that as much as 89% of concussions are either missed or misdiagnosed currently, resulting in ineffective or inappropriate medical care.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Associate Professor Karen Hind at Durham University is to take a central role in the study. Notably, she lead the first independent study on the health of retired rugby players, and is currently researching short and long term risks from injury from sports.

“We’re very excited to be working on this study. Cognetivity’s unique technology represents a promising way to assess cognitive health in athletes at risk of concussion, post concussion and in relation to sub-concussions. This study is part of our overall programme of research through which we seek to investigate and provide strategies to improve athlete health and welfare,” said Dr Hind.

Cognetivity Neurosciences last traded at $0.355 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Cognetivity: Utilizing AI for Early Alzheimer’s Intervention

Sina Habibi, Co-founder & CEO of Cognetivity Neurosciences (CSE: CGN) sits down with us today...

Wednesday, June 14, 2023, 01:30:00 PM

Cognetivity Neurosciences To Deploy Wellness App With Dutch Telehealth Firm

Cognetivity Neurosciences (CSE: CGN) has reached the commercialization stage for one of its products. The...

Tuesday, March 2, 2021, 09:31:13 AM

Cognetivity Partners With UK National Health Service For New Remote Brain Health Clinic

Cognetivity Neuroscience (CSE: CGN) this morning indicated that it continues to see adoption of its...

Wednesday, July 14, 2021, 09:25:00 AM

Cognetivity To Assist In Effective Delivery Of Recently Approved Alzheimer’s Drugs

Cognetivity Neurosciences (CSE: CGN) is set to benefit from a recent ruling by the Centers...

Tuesday, June 6, 2023, 10:02:40 AM

Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval

Monday was a very big day for companies who are in the business to help...

Wednesday, June 9, 2021, 11:22:00 AM